3SBio hits the big time with $6 billion cancer drug deal 三生制药60亿美元出海创纪录 同类靶点海外授权大单频现
The pharma giant Pfizer has bought international rights to the experimental cancer therapy and will take a $100 million equity stake in the Chinese drug developer 辉瑞还将于协议生效日认购三生制药价值1亿美元的普通股股份，进一步实现价值长期绑定。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.